Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$49.00
-0.3%
$51.22
$47.58
$70.93
$99.59B0.3915.53 million shs9.15 million shs
GigaCloud Technology Inc. stock logo
GCT
GigaCloud Technology
$37.00
-0.2%
$33.23
$4.93
$45.18
$1.51B2.273.14 million shs3.81 million shs
Barclays Women in Leadership ETN stock logo
WIL
Barclays Women in Leadership ETN
$86.93
$86.93
$78.50
$103.13
$3.65MN/A450 shsN/A
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
+0.43%+1.30%-5.37%-1.94%-30.29%
GigaCloud Technology Inc. stock logo
GCT
GigaCloud Technology
+6.92%+14.23%+37.83%+68.36%+605.13%
Barclays Women in Leadership ETN stock logo
WIL
Barclays Women in Leadership ETN
+0.00%0.00%+0.00%+0.00%+0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
4.5902 of 5 stars
2.15.03.34.02.41.71.9
GigaCloud Technology Inc. stock logo
GCT
GigaCloud Technology
1.9778 of 5 stars
1.52.00.00.02.62.53.1
Barclays Women in Leadership ETN stock logo
WIL
Barclays Women in Leadership ETN
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
2.11
Hold$61.1824.85% Upside
GigaCloud Technology Inc. stock logo
GCT
GigaCloud Technology
3.00
Buy$35.00-5.41% Downside
Barclays Women in Leadership ETN stock logo
WIL
Barclays Women in Leadership ETN
0.00
N/AN/AN/A

Current Analyst Ratings

Latest WIL, BMY, and GCT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/18/2024
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$51.00 ➝ $52.00
4/2/2024
GigaCloud Technology Inc. stock logo
GCT
GigaCloud Technology
Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$28.00 ➝ $35.00
4/1/2024
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform
3/11/2024
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
Societe Generale
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold
2/6/2024
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$58.00 ➝ $51.00
2/6/2024
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
Redburn Atlantic
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$77.00 ➝ $54.00
(Data available from 4/23/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$45.01B2.21$12.47 per share3.93$14.49 per share3.38
GigaCloud Technology Inc. stock logo
GCT
GigaCloud Technology
$703.83M2.14$2.54 per share14.55$7.14 per share5.18
Barclays Women in Leadership ETN stock logo
WIL
Barclays Women in Leadership ETN
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$8.03B$3.8612.696.931.4817.83%50.95%16.67%4/25/2024 (Confirmed)
GigaCloud Technology Inc. stock logo
GCT
GigaCloud Technology
$94.11M$2.3016.0910.16N/A13.37%36.40%15.41%5/22/2024 (Estimated)
Barclays Women in Leadership ETN stock logo
WIL
Barclays Women in Leadership ETN
N/AN/A0.00N/AN/AN/AN/AN/A

Latest WIL, BMY, and GCT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/25/2024N/A
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
-$4.5050N/A+$4.5050N/AN/AN/A  
3/15/2024Q4 2023
GigaCloud Technology Inc. stock logo
GCT
GigaCloud Technology
$0.58$0.87+$0.29$0.87$220.30 million$244.74 million
2/2/202412/31/2023
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$1.55$1.70+$0.15$2.53$11.19 billion$11.48 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$2.404.90%+8.20%62.18%N/A
GigaCloud Technology Inc. stock logo
GCT
GigaCloud Technology
N/AN/AN/AN/AN/A
Barclays Women in Leadership ETN stock logo
WIL
Barclays Women in Leadership ETN
N/AN/AN/AN/AN/A

Latest WIL, BMY, and GCT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/1/2024
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
quarterly$0.604.72%4/4/20244/5/20245/1/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
1.24
1.43
1.31
GigaCloud Technology Inc. stock logo
GCT
GigaCloud Technology
N/A
1.91
1.27
Barclays Women in Leadership ETN stock logo
WIL
Barclays Women in Leadership ETN
N/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
76.41%
GigaCloud Technology Inc. stock logo
GCT
GigaCloud Technology
34.94%
Barclays Women in Leadership ETN stock logo
WIL
Barclays Women in Leadership ETN
N/A

Insider Ownership

CompanyInsider Ownership
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
0.09%
GigaCloud Technology Inc. stock logo
GCT
GigaCloud Technology
45.30%
Barclays Women in Leadership ETN stock logo
WIL
Barclays Women in Leadership ETN
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
34,1002.03 billion2.02 billionOptionable
GigaCloud Technology Inc. stock logo
GCT
GigaCloud Technology
1,36240.69 millionN/ANot Optionable
Barclays Women in Leadership ETN stock logo
WIL
Barclays Women in Leadership ETN
2,02042,000N/ANot Optionable

WIL, BMY, and GCT Headlines

No headlines for this company have been tracked by MarketBeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Bristol-Myers Squibb logo

Bristol-Myers Squibb

NYSE:BMY
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.
GigaCloud Technology logo

GigaCloud Technology

NASDAQ:GCT
GigaCloud Technology Inc. provides end-to-end B2B ecommerce solutions for large parcel merchandise in the United States and internationally. The company offers GigaCloud Marketplace integrates product discovery to payments to logistics tools into one easy-to-use platform. Its marketplace connects manufacturers primarily in Asia with resellers in the United States, Asia, and Europe to execute cross-border transactions across furniture, home appliance, fitness equipment, and other large parcel categories. The company was formerly known as Oriental Standard Human Resources Holdings Limited and changed its name to GigaCloud Technology Inc. in February 2021. GigaCloud Technology Inc. was incorporated in 2006 and is headquartered in El Monte, California.
Barclays Women in Leadership ETN logo

Barclays Women in Leadership ETN

NYSEARCA:WIL